Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease

ConclusionReadily identifiable predictors can be used to identify subgroups with chronic CAD and/or PAD at elevated risk of MACE and/or MALE. Further research is required to understand the degree to which these subgroups may benefit from early identification and treatment with secondary prevention therapies.FundingJanssen Pharmaceuticals.

http://link.springer.com/10.1007/s12325-019-01132-z

Source: Advances in Therapy - November 7, 2019 Category: Drugs & Pharmacology Source Type: research